Viewing Study NCT03634150


Ignite Creation Date: 2025-12-24 @ 5:01 PM
Ignite Modification Date: 2026-02-26 @ 6:03 AM
Study NCT ID: NCT03634150
Status: WITHDRAWN
Last Update Posted: 2021-10-26
First Post: 2018-06-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy of IV Nerofeā„¢ Followed by Doxorubicin, In Metastatic Ovarian Cancer and Triple Negative Breast Cancer
Sponsor: Immune System Key Ltd
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: ISK-N103
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators